By Stephen Levin
Few subjects within cardiology have been as controversial over the last few years as vulnerable plaque (VP). Once thought to...
InfraReDx: Saved by Angels (and a VC)
A rare combination of angels and the sole interested VC brought InfraReDx back from failure's door in search of a new way to identify the biggest mystery behind heart attacks--vulnerable plaque.